Liangwei Yang

747 total citations · 1 hit paper
17 papers, 594 citations indexed

About

Liangwei Yang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Liangwei Yang has authored 17 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Liangwei Yang's work include Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Liangwei Yang is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Liangwei Yang collaborates with scholars based in China, South Korea and Hong Kong. Liangwei Yang's co-authors include Jin Zhang, Qingwen Li, Lixing Kang, Zequn Wang, Shuchen Zhang, Shibin Deng, Xiao Wang, Kuo Qi, Xuedong Bai and Feng Ding and has published in prestigious journals such as Nature, Nature Communications and Medicine.

In The Last Decade

Liangwei Yang

15 papers receiving 587 citations

Hit Papers

Arrays of horizontal carbon nanotubes of controlled chira... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Arrays of horizontal carbon nanotubes of controlled chirality grown using designed catalysts
    2017 353 citations Shuchen Zhang, Lixing Kang et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangwei Yang China 7 413 149 129 73 59 17 594
Takashi Yoda Japan 7 320 0.8× 128 0.9× 166 1.3× 44 0.6× 58 1.0× 27 633
Shi Guo France 16 421 1.0× 333 2.2× 121 0.9× 93 1.3× 61 1.0× 26 712
Mengjiao Zhang China 14 350 0.8× 131 0.9× 371 2.9× 115 1.6× 41 0.7× 60 776
Lijun He China 9 565 1.4× 183 1.2× 171 1.3× 42 0.6× 34 0.6× 42 756
Qiankun Li China 14 255 0.6× 86 0.6× 208 1.6× 46 0.6× 31 0.5× 30 548
Ruhai Tian United States 9 249 0.6× 389 2.6× 204 1.6× 129 1.8× 43 0.7× 15 680
Argiris Kolokithas‐Ntoukas Greece 13 207 0.5× 359 2.4× 43 0.3× 84 1.2× 63 1.1× 24 592
Beibei Li China 10 228 0.6× 91 0.6× 86 0.7× 45 0.6× 24 0.4× 25 427
Welley Siu Loc United States 10 237 0.6× 103 0.7× 110 0.9× 73 1.0× 21 0.4× 13 408

Countries citing papers authored by Liangwei Yang

Since Specialization
Citations

This map shows the geographic impact of Liangwei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangwei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangwei Yang more than expected).

Fields of papers citing papers by Liangwei Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangwei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangwei Yang. The network helps show where Liangwei Yang may publish in the future.

Co-authorship network of co-authors of Liangwei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Liangwei Yang. A scholar is included among the top collaborators of Liangwei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangwei Yang. Liangwei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Yu, Shiwen, et al.. (2024). Olink Proteomics-Based Exploration of Immuno-Oncology-Related Biomarkers Leading to Lung Adenocarcinoma Progression. Journal of Proteome Research. 23(8). 3674–3681. 2 indexed citations
3.
Zhang, Siqi, et al.. (2024). Predicting the risk of lung cancer using machine learning: A large study based on UK Biobank. Medicine. 103(16). e37879–e37879. 4 indexed citations
4.
5.
Zhang, Chong, Liangwei Yang, Huangkai Zhu, et al.. (2024). A heterogeneous tumor immune microenvironment of uncommon epidermal growth factor receptor mutant non‐small cell lung cancer. Cancer Science. 115(9). 3143–3152. 2 indexed citations
6.
Wang, Minghui, Yongmei Dai, Duoguang Wu, et al.. (2022). Concordance Study of a 520-Gene Next-Generation Sequencing-Based Genomic Profiling Assay of Tissue and Plasma Samples. Molecular Diagnosis & Therapy. 26(3). 309–322. 24 indexed citations
7.
Yang, Minglei, et al.. (2022). Research progress on the relationship between the TOR signaling pathway regulator, epigenetics, and tumor development. Frontiers in Genetics. 13. 1006936–1006936. 2 indexed citations
8.
Dong, Caijun, et al.. (2022). Circ-PGAM1 Enhances Matrine Resistance of Non-Small Cell Lung Cancer via the miR-326/CXCR5 Axis. Cancer Biotherapy and Radiopharmaceuticals. 39(8). 593–599. 3 indexed citations
9.
Yang, Minglei, Weiyan Sun, Long Wang, et al.. (2022). Curcumin Loaded Polycaprolactone Scaffold Capable of Anti-Inflammation to Enhance Tracheal Cartilage Regeneration. SSRN Electronic Journal. 1 indexed citations
10.
Yang, Minglei, Weiyan Sun, Long Wang, et al.. (2022). Curcumin loaded polycaprolactone scaffold capable of anti-inflammation to enhance tracheal cartilage regeneration. Materials & Design. 224. 111299–111299. 14 indexed citations
11.
Ni, Junjun, Liangwei Yang, Huangkai Zhu, et al.. (2021). A patient with metastatic non-small cell lung cancer who received pembrolizumab monotherapy after stereotactic body radiotherapy had progression-free survival of nearly 5 years: a case report. Annals of Palliative Medicine. 10(4). 4999–5009. 6 indexed citations
12.
13.
Yu, Xiuchong, et al.. (2020). Downregulated Expression of linc-ROR in Gastric Cancer and Its Potential Diagnostic and Prognosis Value. Disease Markers. 2020. 1–7. 10 indexed citations
14.
Yang, Liangwei, Xiuchong Yu, Jiaming Zhou, et al.. (2019). Downregulated Expression of hsa_circ_0005556 in Gastric Cancer and Its Clinical Significance. Disease Markers. 2019. 1–7. 10 indexed citations
15.
Yu, Xiuchong, et al.. (2019). Reduced expression of circRNA hsa_circ_0067582 in human gastric cancer and its potential diagnostic values. Journal of Clinical Laboratory Analysis. 34(3). e23080–e23080. 27 indexed citations
16.
Zhang, Shuchen, Lixing Kang, Xiao Wang, et al.. (2017). Arrays of horizontal carbon nanotubes of controlled chirality grown using designed catalysts. Nature. 543(7644). 234–238. 353 indexed citations breakdown →
17.
Hu, Yue, Lixing Kang, Qiuchen Zhao, et al.. (2015). Growth of high-density horizontally aligned SWNT arrays using Trojan catalysts. Nature Communications. 6(1). 6099–6099. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takashi Yoda Breakdown of academic impact, for papers by Shi Guo Breakdown of academic impact, for papers by Mengjiao Zhang Breakdown of academic impact, for papers by Lijun He Breakdown of academic impact, for papers by Qiankun Li Breakdown of academic impact, for papers by Ruhai Tian Breakdown of academic impact, for papers by Argiris Kolokithas‐Ntoukas Breakdown of academic impact, for papers by Beibei Li Breakdown of academic impact, for papers by Welley Siu Loc
Rankless by CCL
2026